COVID-19 Updates
Latest News
Long COVID hitting some states, minorities, women harder
The survey found that women, smokers, and those who had severe COVID-19 infections are most likely to have the disorder.
Feature
Doctor’s checklist for treating long COVID patients
Emerging research has identified a checklist of sorts that doctors should consider when a patient seeks care for what appears to be long COVID.
News from the FDA/CDC
Single bivalent COVID booster is enough for now: CDC
Booster strength wanes after a few months, spurring discussions of whether people at high risk of getting a severe case of COVID may need more...
From the Journals
Negative expectations of COVID shots may amplify side effects
It fits the psychosomatic role of “nocebo effects.”
From the Journals
Nasal COVID treatment shows early promise against multiple variants
Unlike a COVID vaccine that boosts a person’s immune system as protection, the antiviral nasal spray works more directly by blocking the virus,...
From the Journals
High-dose prophylactic anticoagulation benefits patients with COVID-19 pneumonia
Previous studies of anticoagulation strategies for noncritically ill and critically ill patients with COVID-19 pneumonia have shown contrasting...
From the Journals
COVID-19 potentially induced adult-onset IgA vasculitis
A 41-year-old woman developed IgA vasculitis associated with pulmonary-renal syndrome after COVID-19 infection.
Commentary
COVID can mimic prostate cancer symptoms
“I had none of those previously reported experiences that could suddenly trigger a spike in PSA.”
Feature
NOVIDs: Do some have the genes to dodge COVID?
Some in the U.S. have apparently managed to avoid the virus, data suggest.
From the Journals
Factors linked with increased VTE risk in COVID outpatients
While the overall risk for VTE was low, age of at least 55 years, being male, and having a BMI of at least 30 and history of VTE increased the...
Conference Coverage
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed but a survival benefit is observed.